SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-178147
Filing Date
2017-05-22
Accepted
2017-05-22 16:49:44
Documents
6
Effectiveness Date
2017-05-22

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d399411ds8.htm S-8 57788
2 EX-4.12 d399411dex412.htm EX-4.12 141673
3 EX-4.14 d399411dex414.htm EX-4.14 58029
4 EX-5.1 d399411dex51.htm EX-5.1 7441
5 EX-23.1 d399411dex231.htm EX-23.1 1238
6 GRAPHIC g399411g88e02.jpg GRAPHIC 5917
  Complete submission text file 0001193125-17-178147.txt   275366
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-218167 | Film No.: 17861523
SIC: 2834 Pharmaceutical Preparations